$4.57
-0.13-2.77%
Last update: Oct 23, 6:04 PM
Nuvation Bio Inc (NUVB) Stock Price, Quote, News & History
NUVBNYSE
Nuvation Bio (NUVB) stock jumps 6% after early FDA label update for IBTROZI, highlighting over 4 years of clinical benefit in ROS1+ NSCLC.
You can purchase shares of Nuvation Bio (NYSE:NUVB) through any online brokerage.
Other companies in Nuvation Bio’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Nuvation Bio has a consensus price target of $10.88.
The stock price for Nuvation Bio (NYSE: NUVB) is $4.58 last updated October 23, 2026 at 6:04 PM EDT.
There are no upcoming dividends for Nuvation Bio.
Nuvation Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Nuvation Bio.
Nuvation Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective,...
